Search bioRxiv⌕ Search

Biology subjects

Mohammdkhani, A.

Publications and source records attributed to Mohammdkhani, A..

2 recordsLinked to original sources

Chemogenetic stimulation of a retinal circuit activates brain noradrenergic neurons, prevents apoptosis, and suppresses depression-like behaviors

A chronically dysregulated locus coeruleus (LC) system gives rise to mood disorders. In particular, prolonged LC hyperactivity often underlies stress disorders, whereas chronically reduced function often underlies symptoms of depression. Owing to its location deep in the brainstem, LC is difficult to access which limits translational approaches that involve manipulating these neurons. Here, we circumvent this problem by utilizing the retina as a chemogenetic target for commandeering a multsynaptic circuit to LC. We show that activation of this pathway can prevent depression-like behavior and associated pathology of the LC-noradrenergic (NA) system caused by light deprivation. Additionally, we show that melanopsin-containing intrinsically photosensitive retinal ganglion cells (ipRGCs) are the likely cell type responsible for initiating activity in this pathway. By capitalizing on this ocular route of designer receptor delivery, we demonstrate a novel, minimally-invasive method for manipulating this deep-brain circuit that is relevant to a wide array of neuropsychiatric disorders.

neuroscience↗

Orexin-1 receptor signaling in ventral pallidum mediates demand for the opioid remifentanil

Signaling at the orexin-1 receptor (Ox1R) is important for motivation for various drugs of abuse. Recently, our laboratory showed that systemic blockade of Ox1Rs decreased motivation for the potent and short-acting opioid remifentanil (Porter-Stransky et al, 2017). However, the central sites through which orexin acts to mediate motivation for opioids are not known. Here, we investigated ventral pallidum (VP) as a potential site of orexin action, as VP is a known mediator of opioid reward and is densely innervated by orexin-immunoreactive fibers. We used a within-session behavioral economics (BE) paradigm in which remifentanil price (responses/{micro}g iv remifentanil) was sequentially increased throughout the session. Rats were implanted with bilateral cannulae into VP, through which microinjections of SB334867 (SB), and orexin 1 receptor (Ox1R) antagonist, were given prior to BE testing. Rats were then extinguished and subjected to cue-induced reinstatement following intra-VP SB microinjection. We found that inhibition of Ox1R signaling in VP reduced both motivation (increased demand elasticity) for remifentanil and cued reinstatement of extinguished remifentanil-seeking without affecting baseline consumption or general locomotor activity. These effects were specific to the VP, as control injections of SB immediately dorsal to VP did not affect remifentanil-seeking. Together, these findings indicate a selective role of Ox1R signaling in VP in motivation and relapse for the opioid remifentanil.

animal behavior and cognition↗